WINNIE BOSIRE: Open Payments
NPI 1801533179 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 17 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $1,092 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $432 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Validus Pharmaceuticals LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, REXULTI, SPRAVATO, EQUETRO, COBENFY, CAPLYTA, Jornay PM.
Industry payments across WA — which companies pay providers there.
